Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials

January 19th, 2017 - Ryan Allway

Lexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) and NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) are pleased to announce the successful development and initial trial of the industry’s first zero-sugar cannabinoid / pterostilbene edible tablet utilizing both Neutrisci’s and Lexaria’s proprietary and patented technologies. Neutrisci’s proprietary pterostilbene tablet formula was […]

InMed Pharma Appoints Eli Lilly Finance Executive to Board of Directors

January 18th, 2017 - Ryan Allway

InMed Pharmaceuticals Inc. (OTCQB: IMLFF) (CSE: IN), a cannabis biopharmaceutical company specializing in the development of novel cannabinoid therapies and delivery mechanisms, recently announced that Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly & Company joined its Board of Directors. “Martin Bott has established a significant leadership position in financial and […]

Abattis Explores Diversifying with a Strategic Acquisition

January 18th, 2017 - Ryan Allway

Abattis Bioceuticals Corp. (OTC: ATTBF) (CNS-X: ATT), a specialty agricultural technology firm focused on the legal cannabis industry, recently commissioned an independent valuation on Green Nature Health Care Products Inc. in advance of a potential strategic acquisition. The move would follow the company’s international licensing and co-branding agreement signed in November of last year and […]

Invictus MD Strategies Outlines Vision in Exclusive Interview with CFN

January 18th, 2017 - Ryan Allway

Invictus MD Strategies Inc. (CSE: IMH) (OTC Pink: IVITF) (FRA: 8IS) is an investment company that provides capital and expertise to emerging canna-businesses. Over the past two years, the company’s exceptional management team has executed several transactions that generated significant value for shareholders. The deals with the biggest upside, however, are the company’s equity interests […]

InMed Pharmaceuticals Appoints Martin Bott, Eli Lilly Exec, to Board of Directors

January 18th, 2017 - Ryan Allway

InMed Pharmaceuticals, Inc. (“InMed”) (CSE: IN; OTCQB: IMLFF), today announced that Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly & Company, has been appointed to InMed Board of Directors effective immediately. Mr. Bott brings over 28 years of senior financial and executive leadership to InMed’s Board of Directors. “Martin Bott has […]

Medical Marijuana Secures Partnership with Key Pharmaceutical Distributor

January 18th, 2017 - Ryan Allway

The hemp industry may be confronting some obstacles in the United States, but many Latin American countries have embraced the plant’s potential. For instance, Mexico’s COFEPRIS approved the impact of CBD oil for epilepsy treatment; Brazil’s ANVISA legalized CBD for various therapeutic uses; and Chile approved a measure legalizing the cultivation and sale of medical […]

Maple Leaf Prepares for Pre-License Inspection

January 17th, 2017 - Ryan Allway

Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) is pleased to announce that with the recent notice from Health Canada that Maple Leaf has advanced from Security Clearance into Stage 5 Review, the Company can now start planning the renovation of its 80,000 square foot greenhouse complex in Telkwa, British Columbia in preparation […]

Tetra BioPharma (GRPOF): Standing on the Right Side of Regulation (Plus New Interview)

January 17th, 2017 - Ryan Allway

The cannabis industry could reach $50 billion in annual revenue by 2026, according to Cowen & Co., but capitalizing on the drug’s enormous potential is not easy. The United States government has permitted individual states to legalize the drug, but the Drug Enforcement Administration recently cracked down on cannabidiol (CBD) makers and President Trump’s cabinet […]

Kalytera Enters into Binding Letter of Intent to Acquire Talent Biotechs and its Phase 2 Clinical-Stage Graft versus Host Disease Program

January 16th, 2017 - Ryan Allway

Kalytera Therapeutics, Inc. (TSXV:KALY) (“Kalytera”) is pleased to announce that it has entered into a binding letter of intent (the “LOI”) to acquire all of the issued and outstanding securities of Talent Biotechs Ltd. (“Talent”), a privately held, Israeli-based developer of proprietary cannabidiol (“CBD”) therapeutics (the “Transaction”). Under the terms of the LOI, Kalytera has […]

Leading Edge Expositions Appoints Scott Giannotti, Managing Director for the 4th Annual Cannabis World Congress & Business Expositions

January 13th, 2017 - Ryan Allway

Scott Giannotti has been named Managing Director for the Cannabis World Congress & Business Expositions (CWCBExpo) produced by Leading Edge Expositions, LLC.  In this new position, Giannotti will lead business development and oversee the international sales strategy. Giannotti’s primary focus will be on establishing new partnerships and nurturing exhibitor relationships for the leading trade events […]

Oaksterdam University Hosts Panel at High Times Business Summit

January 12th, 2017 - Ryan Allway

Oaksterdam University, an internationally recognized cannabis college, will host an exclusive panel at the High Times Business Summit 2017 at the Los Angeles Convention Center in Los Angeles, California on January 19-20, 2017. The event aims to unite the fields of politics, entrepreneurship, and legalization by bringing together esteemed guest speakers and symposiums tailored to […]

Former President & CEO of Arrowhead Spring Water, Donald Wood, Joins Laguna

January 12th, 2017 - Ryan Allway

Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Laguna”) is pleased to announce that Donald Wood, former President/CEO of Arrowhead Spring Water Ltd., has joined the Laguna Blends Advisory Board. Donald (“Don”) Wood is a business consultant with an exceptional sales and management background specializing in bottled water and FMCG. Don has […]

NutraFuels (NTFU) Ramps Up Revenue, Inks Partnerships

January 12th, 2017 - Ryan Allway

Many microcap companies are full of promises and empty on results, but NutraFuels Inc. (OTC Pink: NTFU) has proven that it can scale revenue higher. During the 9-month period ended September 30, 2016, the company’s revenue increased 111.2% to $260,471 and gross margins improved from 14.2% to 58.8%, which helped decrease its net loss by […]

OrganiGram (OGRMF) Gears Up for Recreational Legalization

January 11th, 2017 - Ryan Allway

Prime Minister Justin Trudeau’s election in October 2015 put Canada on a path to legalize both medical and recreational cannabis on a federal level. Over the next 12-18 months, the government is expected to update the Access to Cannabis for Medical Purposes Regulations (ACMPR) to address both medical and recreational cannabis and pass legislation to […]

InMed (OTCQB: IMLFF) CEO Discusses R&D Pipeline on BNN

January 10th, 2017 - Ryan Allway

InMed Pharmaceuticals Inc. (OTCQB: IMLFF) (CSE: IN), a pre-clinical biopharmaceutical firm developing novel cannabinoid therapies, was recently featured on Canada’s Business News Network (BNN). In the interview, CEO Eric A. Adams discusses the cannabis plant’s enormous potential for new therapies in the pharmaceutical industry and highlights the company’s R&D pipeline targeting serious medical conditions like […]

NutraFuels Begins Development on Five CBD Sprays

January 9th, 2017 - Ryan Allway

NutraFuels Inc. (“NutraFuels” or “NTFU”) (OTC PINK: NTFU) today announced that the company is in the process of completing a new brand identity for it’s newly developed oral spray CBD products named NutraHemp CBD. NTFU has started production on five CBD oral spray products to help support various daily health and wellness needs. The company’s […]

Laguna Blends (LAGBF) Launches New Shots & Closes in on Carlsbad Deal (Plus New CEO Interview)

January 9th, 2017 - Ryan Allway

Laguna Blends Inc. (OTC Pink: LAGBF), a leading distributor and marketer of hemp and cannabidiol (CBD) products, recently announced the launch of new ‘shot’ products and intends to close its acquisition of Carlsbad Naturals in the next couple of weeks. These events represent important catalysts that investors should watch over the coming quarters since they […]

Maple Leaf Co-Lists on OTCQB

January 6th, 2017 - Ryan Allway

Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) is pleased to announce that OTC Markets Group has approved Maple Leaf ‘s common shares for listing on the OTCQB market beginning on Thursday January 5, 2017 , under the symbol MGWFF. “This dual listing in the United States will help Maple Leaf attract new […]

GB Sciences (GBLX): A Grow Business with a Moonshot in Biopharma

January 6th, 2017 - Ryan Allway

GB Sciences Inc. (OTCQB: GBLX) has spent the past year narrowing its focus and improving its balance sheet to prepare for growth. After securing cultivation and production licenses in Nevada, the company pivoted from an agricultural technology provider to a producer of medical cannabis and an innovator in cannabinoid research and development. The new focus […]

Laguna Continues to Work Towards a Definitive Agreement with Carlsbad

January 5th, 2017 - Ryan Allway

KELOWNA, BC / ACCESSWIRE / January 5, 2017 / Laguna Blends Inc. (CNSX:LAG) (OTC PINK: LAGBF) (LB6A.F) (the “Company” or “Laguna”), announces the LOI for Laguna Blends Inc and Carlsbad Naturals, LLC dba CBD Naturals expired on December 31, 2016. With new management coming into Laguna Blends, both parties have agreed to new terms and […]

Abattis Bioceuticals’ (ATTBF) Northern Vine Labs Could Benefit from New Rules

January 4th, 2017 - Ryan Allway

The Canadian Cannabis Task Force on Legalization and Regulation recently released its final report on cannabis legalization and regulation. In the report, the task force emphasized the need for mandatory laboratory testing to prevent contaminated products from hitting the market. Licensed producers will also be required to ensure that packaging contains accurate descriptions of a […]

Why TEVA’s Cannabis Inhaler is a Big Deal

January 4th, 2017 - Bethan Jenkins

A metered-dose TEVA cannabis inhaler is about to be revealed to the world by TEVA Pharmaceutical Industries Ltd. The Israeli multinational generic drug manufacturer has teamed up with Syqe Medical to circulate the pocket-sized selective-dose cannabis inhalers, which have already been administered to Rambam Health Care Campus patients in Haifa for more than a year. […]

NutraFuels, Inc. (NTFU) Procures Manufacturing Job from BIOS Biochemicals Corp. dba LIDTKE Technologies to Formulate and Package Three Liquid-Based Tincture Drop Nutraceuticals

January 4th, 2017 - Ryan Allway

COCONUT CREEK, FL–(Marketwired – January 04, 2017) – NutraFuels, Inc. (“NutraFuels” or “NTFU”), (OTC PINK: NTFU), today announced that the company recently procured an order from natural health and wellness company LIDTKE by way of new business development partner NFSKIN. NTFU was recently hired just before the Christmas holiday to fulfill a backordered order of […]

GB Sciences Announces Opening of Las Vegas, Nevada, Indoor Cannabis Grow, Moving GB Sciences into a Revenue Generating Stage

January 4th, 2017 - Ryan Allway

LAS VEGAS, Jan. 4, 2017 /PRNewswire/ — GB Sciences Nevada, LLC (“GBSN”), a wholly owned subsidiary of GB Sciences, Inc (“GB Sciences” or the “Company”). (GBLX) is pleased to announce the receipt of the State Registration Certificate for its 28,000 sq. ft. cannabis cultivation facility located at 3550 West Teco Avenue in Las Vegas, Clark […]

Laguna Announces Launch of Energy and Sleep “Shots”

January 4th, 2017 - Ryan Allway

KELOWNA, BC / ACCESSWIRE / January 4, 2017 / Laguna Blends Inc. (CNSX:LAG) (OTC PINK: LAGBF) (LB6A.F) (the “Company” or “Laguna”), announces it has signed a distribution agreement with ISO International, LLC to promote and distribute two new nano CBD Shots in the US. Powered by the unique nano technology for ultimate delivery, Heneplex, a […]

NutraFuels, Inc. (NTFU) Secures Partnership with Breadfruit Tree DBA NFSKIN to Develop, Manufacture and Distribute a Multitude of Nutraceutical Dietary Supplements

January 4th, 2017 - Ryan Allway

COCONUT CREEK, FL–(Marketwired – January 03, 2017) – NutraFuels, Inc. (“NutraFuels” or “NTFU”) (OTC PINK: NTFU) today announced that the company has executed a new business development agreement and partnered with private label skin care and dietary supplement company, NFSKIN to manufacture market and distribute a wide array of liquid based nutraceutical products. Under the […]

Lexaria (LXRP) Technology is a Cannabinoid Breakthrough

January 3rd, 2017 - Ryan Allway

The cannabis industry is expected to reach $50 billion by 2026, according to Cowen & Co., but there are still many hurdles to overcome. Aside from the legality of the drug, culinary experts like Greg Mowery have called cannabinoid-infused products ‘bitter, acrid and unpalatable’ and medical research has highlighted the struggle with metabolism and absorption. […]

CFN Media Interviews OWC Pharmaceuticals Advisor Jeffrey Friedland

January 3rd, 2017 - Ryan Allway

CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, recently released an exclusive interview with Jeffrey Friedland, CEO of Intiva Inc. and member of the Advisory Board for OWC Pharmaceutical Research Corp. (OTCQB: OWCP). Mr. Friedland, author of the book Marijuana: The World’s Most Understood Plant, discusses the legal cannabis […]

Lexaria Engages CFN Media to Cultivate Longer Term Investor Audience

January 3rd, 2017 - Ryan Allway

CFN Media Group (“CFN Media”), the leading agency and digital media network dedicated to legal cannabis, today announced that Lexaria Bioscience Corp. (OTCQB: LXRP) (CNSX: LXX) has engaged CFN Media to conduct a 90-day branding and market visibility program beginning January 3rd, 2017. “Lexaria has patented a cannabinoid delivery technology, aimed at the fast-growing edibles […]

Invictus MD Strategies Ends Successful Year with Acquisition

January 3rd, 2017 - Ryan Allway

Invictus MD Strategies Corp. (OTC: IVITF) (CSE: IMH) (FRA: 8IS) has spent the last year building a portfolio of high-quality cannabis businesses. While many publicly traded cannabis firms struggle to achieve revenue, the company has successfully returned $1 million to shareholders and acquired numerous opportunities across various sectors within the rapidly growing industry. In this […]

Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit:

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer